Author

Ryan K. van Laar

Observed names: R K Van Laar, R van Laar, R. Van Laar, Ryan K Van Laar, Ryan K. Van Laar, Ryan Van Laar, Ryan van Laar

Observed institutions: Henry M. Jackson Foundation, Commonwealth Scientific and Industrial Research Organisation, Windber Research Institute, University Medical Center Groningen, Memorial Sloan Kettering Cancer Center, Australian Centre for Disease Preparedness, Walter and Eliza Hall Institute of Medical Research, Walter Reed National Military Medical Center, Peter MacCallum Cancer Centre, Slotervaartziekenhuis, Amsterdam UMC Location University of Amsterdam, Radboud University Medical Center, The Netherlands Cancer Institute, Signal Genetics (United States), Almac (United Kingdom), Agendia (Netherlands), Medisch Centrum Alkmaar, Ian Potter Foundation, Peter MacCallum Cancer Foundation

ORCID: 0000-0003-2828-4175

Observed ORCID: 0000-0003-2828-4175

OpenAlex ID: A5059794592

Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors

2005 · Melissa J. Peart, Gordon K. Smyth, et al. · Proceedings of the National Academy of Sciences · 538

Empirical array quality weights in the analysis of microarray data

2006 · Matthew E Ritchie, Dileepa Diyagama, et al. · BMC Bioinformatics · 307

PDF

Options available—from start to finish—for obtaining data from DNA microarrays II

2002 · Andrew J. Holloway, Ryan K. van Laar, et al. · Nature Genetics · 250

Gene-Expression and Immunohistochemical Study of Specific T-Cell Subsets and Accessory Cell Types in the Transformation and Prognosis of Follicular Lymphoma

2007 · Annuska M. Glas, Laurent Knoops, et al. · Journal of Clinical Oncology · 246

PDF

Genomic Analysis of a Spontaneous Model of Breast Cancer Metastasis to Bone Reveals a Role for the Extracellular Matrix

2005 · Bedrich L. Eckhardt, Belinda S. Parker, et al. · Molecular Cancer Research · 221

PDF

An Expression-Based Site of Origin Diagnostic Method Designed for Clinical Application to Cancer of Unknown Origin

2005 · Richard W. Tothill, Adam Kowalczyk, et al. · Cancer Research · 215

PDF

Gene Expression Profiling to Identify the Histogenetic Origin of Metastatic Adenocarcinomas of Unknown Primary

2008 · Hugo M. Horlings, Ryan K. van Laar, et al. · Journal of Clinical Oncology · 183

Effect of ASCO/CAP Guidelines for Determining ER Status on Molecular Subtype

2012 · Brenda Deyarmin, Jennifer L. Kane, et al. · Annals of Surgical Oncology · 149

Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary

2008 · J Bridgewater, R van Laar, et al. · British Journal of Cancer · 100

PDF

Development and validation of a plasma-based melanoma biomarker suitable for clinical use

2018 · Ryan Van Laar, Mitchel Lincoln, et al. · British Journal of Cancer · 69

PDF

Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen

2008 · Marleen Kok, Sabine C. Linn, et al. · Breast Cancer Research and Treatment · 65

Implementation of a novel microarray‐based diagnostic test for cancer of unknown primary

2009 · Ryan K. van Laar, Xiao‐Jun Ma, et al. · International Journal of Cancer · 55

Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical use

2014 · Ryan van Laar, Rachel Flinchum, et al. · BMC Medical Genomics · 44

PDF

Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer

2012 · Ryan K Van Laar · BMC Medical Genomics · 39

PDF

Gene expression differences in adipose tissue associated with breast tumorigenesis

2014 · Lori A Sturtz, Brenda Deyarmin, et al. · Adipocyte · 38

PDF

Location of, immunogenicity of and relationships between neutralization epitopes on the attachment protein (G) of Hendra virus

2005 · John R. White, Victoria Boyd, et al. · Journal of General Virology · 33

Validation of a microRNA liquid biopsy assay for diagnosis and risk stratification of invasive cutaneous melanoma

2023 · Ryan Van Laar, Babak Latif, et al. · British Journal of Dermatology · 27

Intensive Cardiovascular Risk Reduction Induces Sustainable Changes in Expression of Genes and Pathways Important to Vascular Function

2014 · Darrell L. Ellsworth, Daniel T. Croft, et al. · Circulation Cardiovascular Genetics · 25

An online gene expression assay for determining adjuvant therapy eligibility in patients with stage 2 or 3 colon cancer

2010 · R K Van Laar · British Journal of Cancer · 22

PDF

Characterisation and validation of Mel38; A multi-tissue microRNA signature of cutaneous melanoma

2019 · Ryan Van Laar, Mitchel Lincoln, et al. · PLoS ONE · 16

PDF

Importance of substantial weight loss for altering gene expression during cardiovascular lifestyle modification

2015 · Darrell L. Ellsworth, Kimberly A. Mamula, et al. · Obesity · 16

PDF

A plasma microRNA biomarker of melanoma as a personalised assessment of treatment response

2018 · Ryan K. van Laar, Mitchel T. Lincoln, et al. · Melanoma Research · 13

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival

2011 · Ryan K. Van Laar · Journal of Molecular Diagnostics · 12

PDF

A Favorable BCL-2 Family Expression Profile May Explain the Increased Susceptibility of the t(11;14) Multiple Myeloma Subgroup to Single Agent Venetoclax

2016 · Jenny Wu, Jeremy Ross, et al. · Blood · 11

BreastPRS is a gene expression assay that stratifies intermediate-risk Oncotype DX patients into high- or low-risk for disease recurrence

2013 · Timothy M. D’Alfonso, Ryan K. van Laar, et al. · Breast Cancer Research and Treatment · 10

Works count: 67

Citation count: 2,744

H-index: 19

I10-index: 25